Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Parnell Pharmaceuticals Holdings Ltd (PARNF) had Revenue of $27.22M for the most recently reported fiscal year, ending 2021-12-31.

Quarterly Annual

Figures for fiscal year ending 2021-12-31

Income Statement Financials
Revenue	$27.22M
Net Income	$-1.07M
Cost of Goods Sold	$11.19M
Gross Profit	$16.03M
Operating Expenses	$23.02M
Operating Income	$4.20M
Non-Operating Income/Expense	$-5.27M
Pre-Tax Income	$-1.07M
Normalized Pre-Tax Income	$-1.07M
Income after Taxes	$-1.07M
Income from Continuous Operations	$-1.07M
Consolidated Net Income/Loss	$-1.07M
Normalized Income after Taxes	$-1.07M
EBIT	$4.20M
EBITDA	$8.23M
Weighted-Average Shares Outstanding (Basic)	28.96M
Weighted-Average Shares Outstanding (Diluted)	28.96M
Earnings per Share (EPS) (Basic)	$-0.04
Earnings per Share (EPS) (Diluted)	$-0.04
Balance Sheet Financials
Current Assets	$8.77M
Property, Plant, and Equipment	$7.29M
Long-Term Assets	$21.36M
Total Assets	$30.13M
Current Liabilities	$8.94M
Long-Term Debt	$43.95M
Long-Term Liabilities	$47.32M
Total Liabilities	$56.26M
Common Equity	$-26.13M
Tangible Shareholders Equity	$-37.43M
Shareholders Equity	$-26.13M
Common Shares Outstanding	29.63M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$4.10M
Cash Flow from Investing Activities	$-3.13M
Cash Flow from Financial Activities	$0.05M
Beginning Cash	$3.03M
End Cash	$3.37M
Increase/Decrease in Cash	$0.34M
Stock-Based Compensation	$0.59M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.98
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	2.47
Debt to Equity Ratio	-1.69
Gross Margin	58.88%
Operating Margin	15.43%
EBIT Margin	15.43%
EBITDA Margin	30.24%
Pre-Tax Profit Margin	-3.92%
Profit Margin	-3.92%
Free Cash Flow	$3.43M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.90
Inventory Turnover	3.98
Receiveable Turnover	16.35
Days Sales in Receivables	22.32
Return on Equity	4.08%
Return on Tangible Equity	2.85%
Return on Assets	-3.54%
Return on Investments	-5.99%
Book Value Per Share	$-0.88
Free Cash Flow per Share	$0.12
Operating Cash Flow per Share	$0.14

Data from Zacks Investment Research, Inc.